血管紧张性心痛:对诊断方法和管理的审查
Kenny Jenkins1, Graziella Pompei1,2, Nandine Ganzorig1
1Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Therapeutic advances in cardiovascular disease
|February 12, 2024
概括
血管性心痛 (VSA) 是一种来自冠状动脉的胸痛,可以导致严重的心脏问题. 本综述涵盖了VSA诊断和管理,重点是针对患有血管性心脏病的患者的有效治疗策略.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
背景情况:
- 血管性心痛 (VSA) 涉及由于冠状动脉的胸痛,导致心肌缺血.
- 它可以与或没有阻塞性冠状动脉疾病发生,并与心血管事件风险增加有关.
研究的目的:
- 审查有关血管节炎 (VSA) 诊断和管理的当前数据.
- 概述一个最佳的治疗顺序VSA.
主要方法:
- 对VSA诊断和治疗现有数据的文献综述.
- 关于管理血管性心痛的信息综合.
主要成果:
- 静脉动脉瘤是一种非阻塞性冠状动脉缺血 (INOCA) 的内型,与突然心脏死亡和急性心肌梗塞等不良事件相关.
- 有效的治疗选择对于管理VSA和改善患者的治疗结果至关重要.
结论:
- 准确的诊断和及时管理VSA是必不可少的.
- 一种结构化的治疗方法可以减轻与血管节性心脏病和INOCA相关的风险.
相关概念视频
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
514
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
514
Antianginal Drugs: Nitrates and β-Blockers
590
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
590
Gastroesophageal Reflux Disease II: Clinical Features and Management
85
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
85
Peptic Ulcer Disease IV: Management
92
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Esophageal Varices-II: Clinical Features and Management
67
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
67


